Found 278 matching trials
SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors PHASE2 Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs PHASE2 The goal of this prospective study is to explore the safety and preliminary...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer PHASE1 This phase I trial studies the side effects and best dose of stereotactic b...
Show More Location
University of Wisconsin Carbone Cancer Center
Learn More & Join Trial
Biomarkers for Risk Stratification in Lung Cancer N/A This is a prospective observational study that will follow patients who und...
Show More Location
Zuckerberg San Francisco General Hospital and Trauma Center
Learn More & Join Trial
Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer PHASE1 The purpose of this study is to determine if the use of exploratory immunol...
Show More Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Learn More & Join Trial
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors PHASE2 This is an open-label, single-arm, Phase II investigator-initiated trial of...
Show More Location
The Second Affiliated Hospital of SchoowUniversity
Learn More & Join Trial
Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND) PHASE1 This study aims to evaluate the safety and efficacy of Ivonescimab, a bispe...
Show More Location
Shandong Cancer Hospital and Institute
Learn More & Join Trial
Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer NA The purpose of this clinical trial is to determine whether using chemothera...
Show More Location
Miami Cancer Institute at Baptist Health, Inc.
Learn More & Join Trial
Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC PHASE1 This phase I trial studies the side effects of atezolizumab, varlilumab, an...
Show More Location
Rutgers Cancer Institute of New Jersey
Learn More & Join Trial
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1,Chemotherapy and Target Therapy for Metastatic Colorectal Cancer PHASE2 To improve the survival in patients with microsatellite stable metastatic c...
Show More Learn More & Join Trial